交易 BioNTech BNTX

BioNTech實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

BioNTech 新聞

張瑋庭 2025 Sep 25, 04:10

寧德時代股價飆升:儲能主導地位推動歷史新高

張瑋庭 2025 Sep 24, 14:10

美國股市在挑戰中展現韌性:解析歷史新高與潛在風險

張瑋庭 2025 Sep 24, 13:10

聯準會理事米蘭大幅降息論點分析:是遠見還是誤判?

林芷柔 2025 Sep 24, 12:10

黃金逼近 3800 美元:機構投資者是否會加入這波漲勢?

許景桓 2025 Sep 24, 09:10

美國就業市場風險猶存,政策不確定性揮之不去

黃達傑 2025 Sep 23, 16:00

Fintech 股票值得關注:Nu Holdings(NU)股票、SOFI 股票

黃達傑 2025 Sep 21, 16:00

QBTS 股票今天上漲 11%:D-Wave Quantum Inc. 發生了什麼事?

黃達傑 2025 Sep 17, 16:00

最佳成長科技股票:CoreWeave (CRWV)、Salesforce (CRM)、Google、Nvidia

黃達傑 2025 Sep 09, 16:00

全球投資市場洞察:CFD交易的優勢與風險

黃達傑 2025 Sep 08, 16:00

Broadcom 股票價格今天上漲超過 3%:AVGO 股票現在值得買入嗎?

最新新聞

顯示更多
林芷柔 2025 Sep 25, 04:20

川普轉變烏克蘭策略:施壓歐洲加大援助力道

許景桓 2025 Sep 25, 02:20

川普向阿拉伯領袖承諾:不會允許以色列吞併約旦河西岸

許景桓 2025 Sep 25, 01:20

克里姆林宮駁斥特朗普的烏克蘭立場轉變,要求提供「真實資訊」

張瑋庭 2025 Sep 24, 15:20

美國財長貝森特不滿鮑爾未明確降息,讚賞聯準會新成員

盧昕穎 2025 Sep 24, 11:21

川普支持率因經濟擔憂下滑:路透社/益普索民調

陳昊然 2025 Sep 24, 09:20

馬克宏敦促川普結束加薩衝突,以角逐諾貝爾和平獎

林芷柔 2025 Sep 24, 08:20

日本央行10月升息?檢視可能性與挑戰

林芷柔 2025 Sep 24, 08:20

小米轉型:雷軍年度演講與新品發布備受矚目

聯絡方式

點差

0.6789

點差(%)

0.6825 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期四

13:31 - 19:59

星期一

13:31-19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

23732162560

流通股份

240398724

收益日期(下一個)

0000-00-00

現金殖利率 

2022-06-17

除息日

2022-06-02

遠期年股息率

0

遠期年現金殖利率

0

每股盈餘

-1.67

了解有關此金融工具的詳細資訊

BioNTech BioNTech SE
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
黃達傑 2025 Sep 21, 16:00

如何在沙烏地阿拉伯投資加密貨幣市場:BTC CFD、ETH CFD、XRP CFD、SOL CFD

黃達傑 2025 Sep 21, 16:00

黃金價格(XAU/USD)超過 $3,714:如何在沙烏地阿拉伯交易黃金CFD?

黃達傑 2025 Sep 21, 16:00

NVIDIA 股票正在趨勢中:如何在沙烏地阿拉伯開始交易 NVDA 股票 CFD?

Trustpilot